GEN1047 for Solid Tumors - First in Human (FIH) Trial
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer, Breast Neoplasms|Endometrial Cancer, Endometrial Neoplasm|Ovarian Cancer, Ovarian Neoplasms|Squamous Non Small Cell Lung Cancer (NSCLC-SCC)
Interventions: BIOLOGICAL: GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive cells.
Sponsor: Genmab